What is the optimal schedule for multiparametric MRS? A magnetic resonance fingerprinting perspective

Clinical magnetic resonance spectroscopy (MRS) mainly concerns itself with the quantification of metabolite concentrations. Metabolite relaxation values, which reflect the microscopic state of specific cellular and sub‐cellular environments, could potentially hold additional valuable information, but are rarely acquired within clinical scan times. By varying the flip angle, repetition time and echo time in a preset way (termed a schedule), and matching the resulting signals to a pre‐generated dictionary – an approach dubbed magnetic resonance fingerprinting – it is possible to encode the spins' relaxation times into the acquired signal, simultaneously quantifying multiple tissue parameters for each metabolite. Herein, we optimized the schedule to minimize the averaged root mean square error (RMSE) across all estimated parameters: concentrations, longitudinal and transverse relaxation time, and transmitter inhomogeneity. The optimal schedules were validated in phantoms and, subsequently, in a cohort of healthy volunteers, in a 4.5 mL parietal white matter single voxel and an acquisition time under 5 minutes. The average intra‐subject, inter‐scan coefficients of variation (CVs) for metabolite concentrations, T1 and T2 relaxation times were found to be 3.4%, 4.6% and 4.7% in‐vivo, respectively, averaged over all major singlets. Coupled metabolites were quantified using the short echo time schedule entries and spectral fitting, and reliable estimates of glutamate+glutamine, glutathione and myo‐inositol were obtained.

[1]  Yonina C. Eldar,et al.  Low‐rank magnetic resonance fingerprinting , 2017, Medical physics.

[2]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[3]  Andrew R. Mayer,et al.  Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study. , 2009 .

[4]  C. Elster,et al.  Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-β therapy on absolute metabolite concentrations , 2002, Magnetic Resonance Materials in Physics, Biology and Medicine.

[5]  O. Volovyk,et al.  Application of phase rotation to STRESS localization scheme at 3 T , 2018, Magnetic resonance in medicine.

[6]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[7]  Jun Shen,et al.  Fast computation of full density matrix of multispin systems for spatially localized in vivo magnetic resonance spectroscopy , 2017, Medical physics.

[8]  R. Gillies,et al.  In vivo magnetic resonance spectroscopy in cancer. , 2005, Annual review of biomedical engineering.

[9]  Jürgen Gieseke,et al.  1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation , 2004, Journal of magnetic resonance imaging : JMRI.

[10]  A. Padhani,et al.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer? , 2015, Diagnostic and interventional radiology.

[11]  Ouri Cohen,et al.  Algorithm comparison for schedule optimization in MR fingerprinting. , 2017, Magnetic resonance imaging.

[12]  Assaf Tal,et al.  The application of magnetic resonance fingerprinting to single voxel proton spectroscopy , 2018, NMR in biomedicine.

[13]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[14]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[15]  H. Lanfermann,et al.  Regional Metabolite Concentrations in Aging Human Brain: Comparison of Short-TE Whole Brain MR Spectroscopic Imaging and Single Voxel Spectroscopy at 3T , 2019, Clinical Neuroradiology.

[16]  O. Henriksen,et al.  Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. , 1995, Magnetic resonance imaging.

[17]  J. Babb,et al.  Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. , 2010, Radiology.

[18]  Akira Matsumura,et al.  Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. , 2002, Magnetic resonance imaging.

[19]  A Horsman,et al.  Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours , 1995, NMR in biomedicine.

[20]  Assaf Tal,et al.  Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS , 2013, Neurology.

[21]  T. Sobów,et al.  Magnetic Resonance Spectroscopy in the Diagnosis of Dementia with Lewy Bodies , 2014, BioMed research international.

[22]  M. Oudkerk,et al.  1H chemical shift imaging characterization of human brain tumor and edema , 2002, European Radiology.

[23]  O. Gonen,et al.  Spectroscopic localization by simultaneous acquisition of the double‐spin and stimulated echoes , 2015, Magnetic resonance in medicine.

[24]  D. Reich,et al.  Reproducibility and optimization of in  vivo human diffusion‐weighted MRS of the corpus callosum at 3T and 7T , 2015, NMR in biomedicine.

[25]  Hoby P Hetherington,et al.  MRSI of the medial temporal lobe at 7 T in explosive blast mild traumatic brain injury , 2014, Magnetic resonance in medicine.

[26]  Phil Lee,et al.  Doubly selective multiple quantum chemical shift imaging and T1 relaxation time measurement of glutathione (GSH) in the human brain in vivo , 2013, NMR in biomedicine.

[27]  Michael Garwood,et al.  Imaging in breast cancer: Magnetic resonance spectroscopy , 2005, Breast Cancer Research.

[28]  Andrea Bergmann,et al.  Statistical Parametric Mapping The Analysis Of Functional Brain Images , 2016 .

[29]  L DelaBarre,et al.  The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. , 2001, Journal of magnetic resonance.

[30]  Dennis W J Klomp,et al.  Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses , 2008, Magnetic resonance in medicine.

[31]  Ying Lu,et al.  Comparison of T1 and T2 metabolite relaxation times in glioma and normal brain at 3T , 2008, Journal of magnetic resonance imaging : JMRI.

[32]  Assaf Tal,et al.  Proton MR spectroscopy correlates diffuse axonal abnormalities with post-concussive symptoms in mild traumatic brain injury. , 2013, Journal of neurotrauma.

[33]  Brian J Soher,et al.  A review of 1H MR spectroscopy findings in Alzheimer's disease. , 2005, Neuroimaging clinics of North America.

[34]  Ponnada A Narayana,et al.  Magnetic Resonance Spectroscopy in the Monitoring of Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[35]  J. Duerk,et al.  Magnetic Resonance Fingerprinting , 2013, Nature.

[36]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[37]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[38]  Ze Wang,et al.  Magnetic Resonance Fingerprinting Using a Fast Dictionary Searching Algorithm: MRF-ZOOM , 2019, IEEE Transactions on Biomedical Engineering.

[39]  Abhishek Banerjee,et al.  T2 measurement of J‐coupled metabolites in the human brain at 3T , 2012, NMR in biomedicine.

[40]  Karl Landheer,et al.  A rapid inversion technique for the measurement of longitudinal relaxation times of brain metabolites: application to lactate in high‐grade gliomas at 3 T , 2016, NMR in biomedicine.

[41]  Chris Boesch,et al.  Two-dimensional linear-combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a Fitting Tool for Arrays of Interrelated Datasets , 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.

[42]  Michael Erb,et al.  Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla , 2003, Magnetic resonance in medicine.

[43]  Assaf Tal,et al.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis , 2020, Magnetic resonance in medicine.

[44]  G. E. Alexander,et al.  Brain metabolite concentration and dementia severity in Alzheimer’s disease , 2001, Neurology.

[45]  Itamar Ronen,et al.  Differences in apparent diffusion coefficients of brain metabolites between grey and white matter in the human brain measured at 7 T , 2012, Magnetic resonance in medicine.

[46]  R. Kauppinen,et al.  Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.

[47]  Lawrence L. Wald,et al.  Simultaneous multislice magnetic resonance fingerprinting with low-rank and subspace modeling , 2017, 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[48]  Justin P. Haldar,et al.  Optimal experiment design for magnetic resonance fingerprinting , 2016, 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[49]  F Barkhof,et al.  Neuronal damage in T1‐hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy , 1999, Annals of neurology.

[50]  Robert Bartha,et al.  Effect of signal‐to‐noise ratio and spectral linewidth on metabolite quantification at 4 T , 2007, NMR in biomedicine.

[51]  S. Holland,et al.  NMR relaxation times in the human brain at 3.0 tesla , 1999, Journal of magnetic resonance imaging : JMRI.

[52]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[53]  Shi-Jiang Li,et al.  Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.

[54]  Yvonne W. Lui,et al.  Diffuse axonal injury in mild traumatic brain injury: a 3D multivoxel proton MR spectroscopy study , 2012, Journal of Neurology.

[55]  C. Laule,et al.  Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite T1 and area , 2010, NMR in biomedicine.

[56]  Oded Gonen,et al.  Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.

[57]  E Moser,et al.  Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.

[58]  Gadi Goelman,et al.  Optimizing the efficiency of high‐field multivoxel spectroscopic imaging by multiplexing in space and time , 2006, Magnetic resonance in medicine.

[59]  Bo Zhu,et al.  MR fingerprinting Deep RecOnstruction NEtwork (DRONE) , 2017, Magnetic resonance in medicine.